{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:50Z","timestamp":1791083330896,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Physiologically based pharmacokinetic (PBPK) modeling can be a useful tool for characterizing nicotine pharmacokinetics (PK) from use of tobacco products. We expand a previously published PBPK model to simulate a nicotine PK profile, following single or multiple use of various tobacco products [cigarettes, smokeless tobacco, and electronic nicotine delivery systems, or a nicotine inhaler (NICOTROL)] The uptake route in the model was designed to allow for three uptake compartments: buccal cavity (BC), upper respiratory tract (URT) (conducting and transitional airways) and lower respiratory tract (alveolar region). Within each region, the model includes product-specific descriptions of the flux of nicotine into plasma, as well as the flux of nicotine from the BC and URT to the gastrointestinal tract. These descriptions are based on regional deposition and diffusion models of nicotine into plasma, which depends on the product type. Regional deposition flux combined with regional differences in physiological parameters (e.g., blood perfusion ratio and tissue thickness) play a key role in the product-specific PK profile of nicotine. The current model describes the slower flux of nicotine into plasma across the BC and URT, as well as the rapid flux known to occur in the alveolar region. Overall, the addition of the BC and respiratory tract compartments to the nicotine model provided simulation results that are comparable to the nicotine time-course plasma concentrations reported from clinical studies for the four product categories simulated.<\/jats:p>","DOI":"10.1038\/s41598-022-05108-y","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T06:04:47Z","timestamp":1642658687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure"],"prefix":"10.1038","volume":"12","author":[{"given":"Ali A.","family":"Rostami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezdi B.","family":"Pithawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Pourhashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheema S.","family":"Muhammad-Kah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadi A.","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie J.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinan","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gogova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"#cr-split#-5108_CR1.1","unstructured":"US Food and Drug Administration. FDA Comprehensive Plan for Tobacco and Nicotine Regulation (accessed 09 March 2021)"},{"key":"#cr-split#-5108_CR1.2","unstructured":"https:\/\/www.fda.gov\/tobacco-products\/ctp-newsroom\/fdas-comprehensive-plan-tobacco-and-nicotine-regulation (2019)."},{"key":"#cr-split#-5108_CR2.1","unstructured":"US Food and Drug Administration. Premarket Tobacco Product Applications and Recordkeeping Requirements, Proposed Rule by the Food and Drug Administration on 09\/25\/2019 (accessed 09 March 2021)"},{"key":"#cr-split#-5108_CR2.2","unstructured":"https:\/\/www.federalregister.gov\/documents\/2019\/09\/25\/2019-20315\/premarket-tobacco-product-applications-and-recordkeeping-requirements (2019)."},{"issue":"2","key":"5108_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0041-008X(92)90297-6","volume":"116","author":"DR Plowchalk","year":"1992","unstructured":"Plowchalk, D. R., Andersen, M. E. & deBethizy, J. D. A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol. Appl. Pharmacol. 116(2), 177\u2013188 (1992).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"5108_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF01064421","volume":"20","author":"DE Robinson","year":"1992","unstructured":"Robinson, D. E., Balter, N. J. & Schwartz, S. L. A physiologically based pharmacokinetic model for nicotine and cotinine in man. J. Pharmacokinet. Biopharm. 20(6), 591\u2013609 (1992).","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"1","key":"5108_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yrtph.2012.10.007","volume":"65","author":"JG Teeguarden","year":"2013","unstructured":"Teeguarden, J. G. et al. A multi-route model of nicotine\u2013cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans. Regul. Toxicol. Pharmacol. 65(1), 12\u201328 (2013).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"5108_CR6","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.3390\/ijerph7093406","volume":"7","author":"H Yamazaki","year":"2010","unstructured":"Yamazaki, H. et al. Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling. Int. J. Envion. Res. Public Health 7, 3406\u20133421 (2010).","journal-title":"Int. J. Envion. Res. Public Health"},{"key":"5108_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.toxlet.2014.03.013","volume":"227","author":"M Gajewska","year":"2014","unstructured":"Gajewska, M., Worth, A., Urani, C., Briesen, H. & Schramm, K.-W. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients. Toxicol. Lett. 227, 189\u2013202 (2014).","journal-title":"Toxicol. Lett."},{"key":"5108_CR8","doi-asserted-by":"publisher","unstructured":"Kovar, L. et al. Comprehensive Parent\u2013Metabolite PBPK\/PD Modeling Insights into Nicotine Replacement Therapy Strategies. Clin Pharmacokinet 59, 1119\u20131134 https:\/\/doi.org\/10.1007\/s40262-020-00880-4 (2020).","DOI":"10.1007\/s40262-020-00880-4"},{"key":"5108_CR9","doi-asserted-by":"publisher","first-page":"100182","DOI":"10.1016\/j.comtox.2021.100182","volume":"20","author":"DE Hines","year":"2021","unstructured":"Hines, D. E., Zhang, J., Chang, X., Bell, S. M. & Lee, K. M. Application of open-source PBPK models in rat-to-human pharmacokinetic extrapolation of oral nicotine exposure. Comput. Toxicol. 20, 100182 (2021).","journal-title":"Comput. Toxicol."},{"key":"5108_CR10","doi-asserted-by":"publisher","first-page":"114826","DOI":"10.1016\/j.taap.2019.114826","volume":"386","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates. Toxicol. Appl. Pharmacol. 386, 114826 (2020).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"5108_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1021\/tx0100901","volume":"14","author":"JF Pankow","year":"2001","unstructured":"Pankow, J. F. A consideration of the role of gas\/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract. Chem. Res. Toxicol. 14(11), 1465\u20131481 (2001).","journal-title":"Chem. Res. Toxicol."},{"key":"5108_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaerosci.2017.11.014","volume":"116","author":"B Asgharian","year":"2018","unstructured":"Asgharian, B., Price, O. T., Rostami, A. A. & Pithawalla, Y. B. Deposition of inhaled electronic cigarette aerosol in the human oral cavity. J. Aerosol. Sci. 116, 34\u201347 (2018).","journal-title":"J. Aerosol. Sci."},{"key":"5108_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaerosci.2018.08.006","volume":"126","author":"B Asgharian","year":"2018","unstructured":"Asgharian, B., Rostami, A. A., Price, O. T. & Pithawalla, Y. B. Regional deposition of inhaled aerosol constituents from Electronic Nicotine Delivery Systems (ENDS) in the respiratory tract. J. Aerosol. Sci. 126, 7\u201320 (2018).","journal-title":"J. Aerosol. Sci."},{"issue":"4","key":"5108_CR14","first-page":"240","volume":"21","author":"AK Armitage","year":"2004","unstructured":"Armitage, A. K., Dixon, M., Frost, B. E., Mariner, D. C. & Sinclair, N. M. The effect of inhalation volume and breath-hold duration on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Beitr\u00e4ge zur Tabakforschung Int. 21(4), 240\u2013249 (2004).","journal-title":"Beitr\u00e4ge zur Tabakforschung Int."},{"issue":"9","key":"5108_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200140090-00003","volume":"40","author":"NG Schneider","year":"2001","unstructured":"Schneider, N. G., Olmstead, R. E., Franzon, M. A. & Lunell, E. The nicotine inhaler. Clin. Pharmacokinet. 40(9), 661\u2013684 (2001).","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"5108_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1007\/s10439-011-0274-9","volume":"39","author":"B Asgharian","year":"2011","unstructured":"Asgharian, B. et al. Derivation of mass transfer coefficients for transient uptake and tissue disposition of soluble and reactive vapors in lung airways. Ann. Biomed. Eng. 39(6), 1788\u20131804 (2011).","journal-title":"Ann. Biomed. Eng."},{"key":"5108_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijpharm.2005.12.039","volume":"311","author":"CL Adrian","year":"2006","unstructured":"Adrian, C. L., Olin, H. B., Dalhoff, K. & Jacobsen, J. In vivo human buccal permeability of nicotine. Int. J. Pharm. 311, 196\u2013202 (2006).","journal-title":"Int. J. Pharm."},{"key":"5108_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/toxsci\/kfv071","volume":"146","author":"RA Corley","year":"2015","unstructured":"Corley, R. A. et al. Comparative risks of aldehyde constituents in cigarette smoke using transient computational fluid dynamics\/physiologically based pharmacokinetic models of the rat and human respiratory tracts. Toxicol. Sci. 146, 65\u201388 (2015).","journal-title":"Toxicol. Sci."},{"key":"5108_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/toxsci\/kfs168","volume":"128","author":"RA Corley","year":"2012","unstructured":"Corley, R. A. et al. Comparative computational modeling of airflows and vapor dosimetry in the respiratory tracts of rat, monkey, and human. Toxicol. Sci. 128, 500\u2013516 (2012).","journal-title":"Toxicol. Sci."},{"key":"5108_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/08958378.2014.896059","volume":"26","author":"JL Campbell","year":"2014","unstructured":"Campbell, J. L., Andersen, M. E. & Clewell, H. J. A hybrid CFD-PBPK model for naphthalene in rat and human with IVIVE for nasal tissue metabolism and cross-species dosimetry. Inhalation Toxicol. 26, 333\u2013344 (2014).","journal-title":"Inhalation Toxicol."},{"key":"5108_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/089583799196718","volume":"11","author":"MS Bogdanffy","year":"1999","unstructured":"Bogdanffy, M. S., Manning, L. A. & Sarangapani, R. High-affinity nasal extraction of vinyl acetate vapor is carboxylesterase dependent. Inhalation Toxicol. 11, 927\u2013941 (1999).","journal-title":"Inhalation Toxicol."},{"key":"5108_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0146-6453(02)00020-9","volume":"32","author":"International Commission on Radiological Protection","year":"2002","unstructured":"International Commission on Radiological Protection. Basic anatomical and physiological data for use in radiological protection reference values. ICRP Publication 89. Ann. ICRP 32, 3\u20134 (2002).","journal-title":"Ann. ICRP"},{"key":"5108_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1567-5769(03)00094-8","volume":"3","author":"S Satoskar","year":"2003","unstructured":"Satoskar, S. et al. Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int. Immunopharmacol. 3, 957\u2013970 (2003).","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"5108_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/btp162","volume":"25","author":"FY Bois","year":"2009","unstructured":"Bois, F. Y. GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25(11), 1453\u20131454 (2009).","journal-title":"Bioinformatics"},{"issue":"9","key":"5108_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i09","volume":"33","author":"K Soetaert","year":"2010","unstructured":"Soetaert, K., Petzoldt, T. & Setzer, R. W. Solving differential equations in R: Package deSolve. J. Stat. Softw. 33(9), 1\u201325 (2010).","journal-title":"J. Stat. Softw."},{"issue":"4","key":"5108_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0009-9236(97)90124-7","volume":"62","author":"SG Gourlay","year":"1997","unstructured":"Gourlay, S. G. & Benowitz, N. L. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin. Pharmacol. Ther. 62(4), 453\u2013463 (1997).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"5108_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/ntr\/ntv220","volume":"18","author":"P Picavet","year":"2015","unstructured":"Picavet, P., Haziza, C., Lama, N., Weitkunat, R. & L\u00fcdicke, F. Comparison of the pharmacokinetics of nicotine following single and ad libitum use of a tobacco heating system or combustible cigarettes. Nicotine Tobacco Res. 18(5), 557\u2013563 (2015).","journal-title":"Nicotine Tobacco Res."},{"issue":"1","key":"5108_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/clpt.1988.107","volume":"44","author":"NL Benowitz","year":"1988","unstructured":"Benowitz, N. L., Porchet, H., Sheiner, L. & Jacob, P. III. Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther. 44(1), 23\u201328 (1988).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"5108_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000138484","volume":"37","author":"D deBethizy","year":"1988","unstructured":"deBethizy, D. et al. Absorption of nicotine from a cigarette that does not burn tobacco. Pharmacology 37(5), 328\u2013332 (1988).","journal-title":"Pharmacology"},{"issue":"6017","key":"5108_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/bmj.1.6017.1043","volume":"1","author":"M Russell","year":"1976","unstructured":"Russell, M., Feyerabend, C. & Cole, P. Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br. Med. J. 1(6017), 1043\u20131046 (1976).","journal-title":"Br. Med. J."},{"issue":"8166","key":"5108_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(80)91010-7","volume":"315","author":"MA Russell","year":"1980","unstructured":"Russell, M. A., Jarvis, M. J. & Feyerabend, C. A new age of snuff?. Lancet 315(8166), 474\u2013475 (1980).","journal-title":"Lancet"},{"issue":"5","key":"5108_CR32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/ntr\/ntv182","volume":"18","author":"AA Lopez","year":"2016","unstructured":"Lopez, A. A. et al. Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: A preliminary report. Nicotine Tobacco Res. 18(5), 720\u2013723 (2016).","journal-title":"Nicotine Tobacco Res."},{"issue":"12","key":"5108_CR33","doi-asserted-by":"publisher","first-page":"e0210147","DOI":"10.1371\/journal.pone.0210147","volume":"13","author":"EL Floyd","year":"2018","unstructured":"Floyd, E. L., Queimado, L., Wang, J., Regens, J. L. & Johnson, D. L. Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol. PLoS ONE 13(12), e0210147 (2018).","journal-title":"PLoS ONE"},{"key":"#cr-split#-5108_CR34.1","unstructured":"Liu, J., Liang, Q., Connell, C., Rimmer, L., Edmiston, J. & Sarkar, M. A pharmacokinetic study to determine plasma nicotine profile from two electronic cigarette prototype products (CVR1.2NS and CVR1.2MS) in adult cigarette smokers. Presented at the 20th Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT), Seattle, WA, February 5-8, 2014 (accessed 09 March 2021)"},{"key":"#cr-split#-5108_CR34.2","unstructured":"https:\/\/sciences.altria.com\/-\/media\/Project\/Altria\/Sciences\/presentations\/4\/Liu---A-Pharmacokinetic-Study-to-Determine-Plasma-Nicotine-Profile-from-Two-Electronic-Cigarette.pdf (2014)."},{"key":"5108_CR35","unstructured":"Pfizer Inc. NICOTROL Inhaler\u2014Pfizer Medical Information (accessed 09 March 2021); https:\/\/www.pfizermedicalinformation.com\/en-us\/nicotrol-inhaler (2008)."},{"key":"#cr-split#-5108_CR36.1","unstructured":"Campbell, J., Rostami, A., Muhammad-Kah, R., Sarkar, M., Liu, J., Kobal, G. & Pithawalla, Y. B. Physiologically based pharmacokinetic model to characterize nicotine kinetics following the use of oral or inhalable products. Presented at the 24th Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT), Baltimore, MD, February 21-24, 2018 (accessed 09 March 2021)"},{"key":"#cr-split#-5108_CR36.2","unstructured":"https:\/\/sciences.altria.com\/library\/-\/media\/Project\/Altria\/Sciences\/library\/conferences\/2018%20SRNT_Rostami-Feb%2023_PRnocrops.pdf (2018)."},{"issue":"1","key":"5108_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ntr\/nts123","volume":"15","author":"H Digard","year":"2012","unstructured":"Digard, H., Proctor, C., Kulasekaran, A., Malmqvist, U. & Richter, A. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tobacco Res. 15(1), 255\u2013261 (2012).","journal-title":"Nicotine Tobacco Res."}],"updated-by":[{"DOI":"10.1038\/s41598-022-06693-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05108-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:13:11Z","timestamp":1669306391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05108-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-810822\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"13 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-022-06693-8","URL":"https:\/\/doi.org\/10.1038\/s41598-022-06693-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Some of the authors are employed by Altria Client Services LLC (ALCS), which also funded the underlying research. ALCS is an affiliate of companies that produce, market and sell tobacco products.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1091"}}